K203489 is an FDA 510(k) clearance for the SEFRIA PCP Oral Fluid Enzyme Immunoassay. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Immunalysis Corporation (Pomona, US). The FDA issued a Cleared decision on April 20, 2021 after a review of 144 days - within the typical 510(k) review window.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.
View all Immunalysis Corporation devices